Glutamic Acid

Glutamic Acid

SCHEMBL7715353

N[C@@H](CCC(=O)O)C(=O)O.Oc1ccccc1

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM8 O00222 2/20 0.67
GRM4 Q14833 2/20 0.67
GRM6 O15303 1/20 0.67
GRIN2D O15399 1/20 0.67
GRIN3B O60391 1/20 0.67
GSR P00390 1/20 0.67
CYP1A2 P05177 1/20 0.67
GRIK1 P39086 1/20 0.67
GRM5 P41594 1/20 0.67
GRIA1 P42261 1/20 0.67
GRIA2 P42262 1/20 0.67
GRIA3 P42263 1/20 0.67
SLC1A3 P43003 1/20 0.67
SLC1A2 P43004 1/20 0.67
SLC1A1 P43005 1/20 0.67
GRIA4 P48058 1/20 0.67
GRIN1 Q05586 1/20 0.67
GRIN2A Q12879 1/20 0.67
GRIK2 Q13002 1/20 0.67
GRIK3 Q13003 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
D-Glutamate SCHEMBL7715349 1.00 GRM8 (0.67) GRM8GRM4GRM6GRIN2DGRIN3B
Glutamine SCHEMBL15269081 0.87 KMT2A (0.68) GRM8GRM4GRM6GRIN2DGRIN3B
Glutamine SCHEMBL15269077 0.87 KMT2A (0.68) GRM8GRM4GRM6GRIN2DGRIN3B
Biphenyl SCHEMBL7780462 0.87 SLC1A3 (0.69) GRM8GRM4GRM6GRIN2DGRIN3B
D-Glutamate SCHEMBL6486892 0.86 GRM8 (0.90) GRM8GRM4GRM6GRIN2DGRIN3B
Tyrosine SCHEMBL22500854 0.86 SLC7A5 (0.71) GRM8GRM4GRM6GRIN2DGRIN3B
Glutamic Acid SCHEMBL11625149 0.86 GRM8 (0.62) GRM8GRM4GRM6GRIN2DGRIN3B
Glutamic Acid SCHEMBL3417216 0.85 SLC1A3 (0.67) GRM8GRM4GRM6GRIN2DGRIN3B
D-Glutamate SCHEMBL3417211 0.85 SLC1A3 (0.67) GRM8GRM4GRM6GRIN2DGRIN3B
D-Glutamate SCHEMBL7782949 0.84 GRIK1 (0.64) GRM8GRM4GRM6GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105777790-B A kind of adjacent carborane phenol derivatives and its preparation method and application 南京远淑医药科技有限公司 2017-11-14 CN disclosed
CN-103039645-A Lotus Fuzhuan brick tea and preparation method thereof HE ZHIHONG 2013-04-17 CN disclosed
US-6436691-B1 CONJUGATE WHICH IS SUBSTANTIALLY NON-IMMUNOGENIC IN HUMANS COMPRISING TARGETING MOIETY CAPABLE OF BINDING WITH TUMOR ASSOCIATED ANTIGEN LINKED TO MUTATED FORM OF CARBOXYPEPTIDASE B ENZYME CAPABLE OF CONVERTING PRODRUG INTO ANTICANCER DRUG ZENECA LIMITED (GB) 2002-08-20 US disclosed
EP-0806964-B1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2002-08-14 EP disclosed
EP-0780167-B1 A method and apparatus for diffusing a chemical solution, a method and apparatus for injecting a liquid, and a method of remedying soil CANON KK (JP) 2000-06-07 EP disclosed
US-5985281-A ANTIBODY DIRECTED ENZYME PRODRUG THERAPY (ADEPT) USING A NON-NATURALLY OCCURING MUTANT FORM OF A HOST ENZYME, ESPECIALLY A MUTANT FORM OF RIBONUCLEASE. ZENECA LIMITED (GB) 1999-11-16 US disclosed
US-5877390-A USING GAS PRESSURE CANON KABUSHIKI KAISHA (JP) 1999-03-02 US disclosed
EP-0844885-A2 CHEMICAL COMPOUNDS ZENECA LIMITED (GB) 1998-06-03 EP disclosed
EP-0806964-A1 CHEMICAL COMPOUNDS ZENECA LIMITED (GB) 1997-11-19 EP disclosed
EP-0780167-A1 A method and apparatus for diffusing a chemical solution, a method and apparatus for injecting a liquid, and a method of remedying soil CANON KABUSHIKI KAISHA (JP) 1997-06-25 EP disclosed
WO-1997007769-A2 CHEMICAL COMPOUNDS ZENECA LIMITED (GB) 1997-03-06 WO disclosed
WO-1996020011-A1 CHEMICAL COMPOUNDS ZENECA LIMITED (GB) 1996-07-04 WO disclosed